RELMADA THERAPEUTICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This is a Current Report (Form 8-K) filed by Relmada Therapeutics, Inc. on June 3, 2020, covering the date of the earliest event reported on June 2, 2020. The company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol RLMD.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or quantitative financial data.
Material Changes
There are no material changes to financial performance or operations reported in this filing. The sole event reported is the update of the company's corporate presentation.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves only to notify the market of the availability of an updated corporate presentation attached as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the content of the updated Corporate Presentation (Exhibit 99.1) for any new strategic or operational information.
- Confirm the trading status of RLMD on The Nasdaq Capital Market.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.